Randolph C. Steer - Sep 7, 2021 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role: Director
Signature: /s/ Brenda S. Furlow as Attorney-in-Fact for Randolph C. Steer pursuant to Power of Attorney previously filed
Stock symbol: TECH
Transactions as of: Sep 7, 2021
Transactions value $: -$3,363,143
Form type: 4
Date filed: 9/9/2021, 04:26 PM
Next filing: Nov 1, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TECH	Common Stock	Options Exercise	$350K	+4K	+78.25%	$87.39	9.11K	Sep 7, 2021	Direct
transaction	TECH	Common Stock	Options Exercise	$367K	+4K	+43.9%	$91.78	13.1K	Sep 7, 2021	Direct
transaction	TECH	Common Stock	Sale	-$1.48M	-2.9K	-22.12%	$509.33	10.2K	Sep 7, 2021	Direct	F1
transaction	TECH	Common Stock	Sale	-$2.35M	-4.6K	-45.05%	$510.23	5.61K	Sep 7, 2021	Direct	F2
transaction	TECH	Common Stock	Sale	-$256K	-500	-8.91%	$511.45	5.11K	Sep 7, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership
transaction	TECH	Stock Option (right to buy)	Options Exercise	$0	-4K	-100%	$0.00^*	0	Sep 7, 2021	Common Stock	4K	$87.39	Direct
transaction	TECH	Stock Option (right to buy)	Options Exercise	$0	-4K	-100%	$0.00^*	0	Sep 7, 2021	Common Stock	4K	$91.78	Direct
holding	TECH	Stock Option (right to buy)						4.26K	Sep 7, 2021	Common Stock	4.26K	$87.34	Direct
holding	TECH	Stock Option (right to buy)						3.99K	Sep 7, 2021	Common Stock	3.99K	$101.19	Direct
holding	TECH	Stock Option (right to buy)						3.13K	Sep 7, 2021	Common Stock	3.13K	$125.05	Direct
holding	TECH	Stock Option (right to buy)						1.9K	Sep 7, 2021	Common Stock	1.9K	$179.84	Direct
holding	TECH	Stock Option (right to buy)						2.01K	Sep 7, 2021	Common Stock	2.01K	$201.64	Direct
holding	TECH	Stock Option (right to buy)						1.51K	Sep 7, 2021	Common Stock	1.51K	$255.69	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $508.978 to $509.769, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $509.98 to $510.597, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $508.978 to $509.769, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $509.98 to $510.597, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.